Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact

AIM: p16 and p53 are frequently altered intracellular pathways in cancers. We investigated the aberrant expression of p16 and its relationship with p53 and HPV status in primary non-small-cell lung carcinoma. PATIENTS & METHODS: Lung tumor tissue microarray (n = 163), immunohistochemical study o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomark Med
Egile Nagusiak: Zhou, Yangying, Höti, Naseruddin, Ao, Minghui, Zhang, Zhen, Zhu, Hong, Li, Ling, Askin, Frederic, Gabrielson, Edward, Zhang, Hui, Li, Qing Kay
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8173521/
https://ncbi.nlm.nih.gov/pubmed/31157548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm-2018-0441
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak